Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data

Published:2024-06 Issue: Volume:47 Page:100768
ISSN:1755-4365
Container-title:Epidemics
language:en
Short-container-title:Epidemics

Author:

Moore Mia^ORCID,Zhu Yifan^ORCID,Hirsch Ian,White Tom^ORCID,Reiner Robert C.,Barber Ryan M.,Pigott David,Collins James K.,Santoni Serena,Sobieszczyk Magdalena E.,Janes Holly

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Reference36 articles.

1. Modeling the effect of exposure notification and non-pharmaceutical interventions on COVID-19 transmission in Washington state;Abueg;NPJ Dig. Med.,2021

2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N. Engl. J. Med.,2021

3. Challenges in reported COVID-19 data: best practices and recommendations for future epidemics;Badker;BMJ Global Health,2021

4. The lightning-fast quest for COVID vaccines — and what it means for other diseases;Ball;Nature,2020

5. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14 2021: a statistical analysis;Barber;Lancet,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP